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Abstract: In the present work, we have studied whether cell death could be induced in 
cortical neurons from rats subjected to different period of O2 deprivation and low glucose 
(ODLG). This “in vitro” model is designed to emulate the penumbra area under ischemia. 
In these conditions, cortical neurons displayed loss of mitochondrial respiratory ability 
however, nor necrosis neither apoptosis occurred despite ROS production. The absence  
of cellular death could be a consequence of increased antioxidant responses such as 
superoxide dismutase-1 (SOD1) and GPX3. In addition, the levels of reduced glutathione 
were augmented and HIF-1/3α overexpressed. After long periods of ODLG (12–24 h) 
cortical neurons showed cellular and mitochondrial membrane alterations and did not 
recuperate cellular viability during reperfusion. This could mean that therapies directed 
toward prevention of cellular and mitochondrial membrane imbalance or cell death through 
mechanisms other than necrosis or apoptosis, like authophagy, may be a way to prevent 
ODLG damage. 
Keywords: cortical neurons; cerebral ischemia; ROS formation; antioxidant defenses; 
mitochondrial membrane potential; free radical; SOD1/caspase-3 
 
OPEN ACCESS
Int. J. Mol. Sci. 2014, 15 2476 
 
 
1. Introduction 
The brain requires a continuous supply of oxygen and glucose to maintain central nervous system 
(CNS) functions. The deprivation resulting from stroke or respiratory failure, can rapidly lead to 
transient or permanent neuronal injury as consequence of reduced energy bioavailability; pump 
function or membrane integrity [1]. Cerebral ischemia is an important cause of death and working 
disability in humans [2,3]. Caspase-3, an effecter enzyme involved in apoptosis [4], may contribute to 
the pathophysiology of cerebral ischemia. Other mechanisms including inflammation and angiogenesis 
together with ROS formation contribute to cell death in stroke [5–8]. However, ROS production 
protects against H2O2 toxicity [9] and may regulate signal transduction pathways under  
physiological [10,11] and pathological conditions [12–15]. However, controversial data suggests that 
glutamate may play a neurotoxic role in cerebral ischemia [16–23]. 
Cerebral artery occlusion can induce apoptosis or necrotic cell death. This occlusion may induce 
differential damages depending of the lack of O2 and nutrients. These zones are the “core” area and the 
“penumbra” area, which are rendered functionally silent but retain alive cells [24]. Many studies have 
shown that neurons from the ischemic penumbra undergo apoptosis rather than necrosis, suggesting 
that this area can be potentially and functionality recovered [25–27], however, the molecular 
mechanisms involved are not well known. 
Hypoxia-inducible factors (HIFs) are transcriptional mediators of adaptive responses that decrease 
oxygen availability, a characteristic of ischemic-hypoxia conditions [28]. HIFs are ubiquitously 
expressed in several mammalian cell types [29]. Since its discovery, the HIFs cascade has been 
extensively studied and plays a role in both physiological, as tissue repair, and pathological  
process [30–32], as ischemia [33,34]. 
The model of oxygen deprivation-low glucose (ODLG) chosen for our study is a reliable and 
validated method to study cellular damage in cortical neurons subjected to partial ischemia (penumbra 
area). In our study, cultured cortical neurons were subjected to oxygen-deprivation and low glucose 
(ODLG model). We studied whether neuronal damage, at different ODLG times (1, 3, 5, 12, and 24 h) 
could exist under these vulnerability conditions, by evaluating whether (1) ROS formation and 
expression of antioxidant enzymes (SOD-1 and GPX3) together with the mitochondrial enzyme 
cytochrome oxidase (CO) might be differentially regulated under ODLG; (2) to study whether  
HIF-1/3α stabilization could prevent neuronal loss in these cortical neurons; (3) evaluate whether 
cellular and membrane mitochondrial integrity were affected by measuring membrane potential after 
ODLG as well as (4) possible cellular dysfunctions of neurotransmission during reperfusion by testing 
Asp, Glu, Gly and GABA release by HPLC. 
2. Results 
2.1. Presence of “HIF” Factor during Hypoxia 
The first objective was to demonstrate whether the cortical neurons cultured, under hypoxia, are 
truly under anoxic conditions. It has been reported that transcription factors (HIF) can be induced in 
cellular and animal models of cerebral ischemia [35,36]; consequently, the presence of this factor in 
our preparations was checked by RT-PCR. Data in Figure 1 indicate that under our experimental 
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conditions, cortical neurons significantly upregulated HIF-1α and HIF-3α transcription factors. 
Reperfusion reversed HIF-1α and HIF-3α upregulation although the values were always higher than 
the controls. 
Figure 1. Induction of HIF 1α (A) and HIF-3α gene expression (B) in cortical neurons 
after exposure to ODLG conditions during 24 h. C = control, ODLG = 24 h treatment, 
ODLG + R = 24 h treatment followed by 24 h reperfusion. ns = no significant (vs. control) 
(***) or (•••) = p < 0.005; (***) = vs. control; (•••) = vs. ischemia with or  
without reperfusion.  
 
Figure 2. Effect of different ODLG treatment time on ROS formation.  
Reperfusion = Cortical neurons after the ODLG treatments were subjected to 24 h  
under a normal atmosphere after the ODLG treatment. Results are means ± SEM of three 
experiments with cells from different cultures, each one performed in triplicate with 
different batches of cells (9 measurements/condition). ns = no significant (vs. control);  
(***) or (•••) = p < 0.005, (*) (vs. control), (•) (vs. ischemia with or without reperfusion). 
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2.2. ROS Formation 
Since oxygen radicals (ROS) are suspected to be involved in cellular injury and death, we analyzed 
whether hypoxia and hypoglycemia (ODLG) could modulate ROS production “in vitro”. Results in 
Figure 2 indicate that cortical neurons subjected to these hypoxic and hypoglycemic conditions, 
generated ROS at the moment in which the cells were in a normal atmosphere. This ROS production 
increased progressively under hypoxia. In addition, when these neurons were subjected to 24 h of 
reperfusion, ROS production was completely reversed, reaching values similar to those in control cells. 
2.3. Cell Viability 
Since ROS formation could play a pivotal role in cell death, cell viability was tested by  
two methods, crystal violet, which measures cell viability (Figure 3A) and the XTT assay, which 
measures the metabolic activity of these neurons (Figure 3B). The crystal violet test showed an 
absence of neuronal loss in cortical neurons at all studied times (Figure 3A). However, the XTT assay 
showed a time-dependent loss of cell viability (Figure 3B). Reperfusion did not reverse the loss of 
viability in cells subjected to 5 to 24 h of ODLG, although at shorter times showed levels similar  
to controls. 
Figure 3. (A) Cells were subjected to ODLG for 0 to 48 h before evaluating cell viability 
with the crystal violet method; (B) Cells were subjected to 3, 5 or 24 h of ODLG times, 
followed or not by reperfusion. Then, cell viability was measured by the XTT assay. 
Results are expressed as means ± SEM from two/three experiments with cells from 
different cultures, each experiment performed in triplicate with different batches of cells 
(6–9 measurements/condition). ns = no significant (vs. control); NS = no significant  
(vs. ischemia with or without reperfusion); (*) = p < 0.05 (vs. control); (***) = p < 0.005 
(vs. control). 
 
2.4. Cellular Death (LDH Assay) 
The lack of cellular viability in the XTT assay has two interpretations: (1) cell death or (2) loss of 
metabolic ability. In order to check these options, LDH activity was also measured to evaluate necrotic 
death and caspase-3 activation (a sensor of apoptosis) was quantified. Results in Figure 4A show that 
cortical neurons at 1 to 24 h of ODLG did not significantly increase their LDH release. 
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Figure 4. Evaluation of cellular death. (A) Necrosis was evaluated by LDH release;  
(B) Apoptosis was evaluated by caspase-3 activity. Results are means ± SEM of  
three experiments with cells from different cultures, each one was performed in triplicate 
with different batches of cells (9 measurements/condition). ns = no significant (vs. control); 
(••) = p < 0.01 (vs. ischemia with or without reperfusion); (***) (vs. control) or  
(•••) = p < 0.005 (vs. ischemia with or without reperfusion).  
 
2.5. Caspase-3 Activation 
Regarding caspase-3 activity, there was a significant proportional decline in caspase-3 activity with 
the increase in ODLG times (Figure 4B). Reperfusion did not reverse the caspase-3 inactivation 
produced by 1–5 h of ODLG. In fact, caspase 3 activity was even lower during reperfusion at this time. 
The inhibitory effects were more evident after 1–3 h of ischemia. Caspase-3 was significantly 
overproduced at 24 h during reperfusion as compared to values obtained in the non reperfused cells. 
2.6. Cytochrome Oxidase 
Results in Figure 5 show that cytochrome oxidase activity (CO), the terminal enzyme of the 
respiratory chain, decreased during the first hour of ODLG but returned to basal values at longer 
hypoxia times. During reperfusion, CO decreased at 1 h of ODLG and reached values close to control 
levels at 3 to 48 h of ODLG. 
2.7. Possible Mechanisms which Protect against ROS Damage 
As our results do not seem to indicate the existence of cellular death, even despite the high ROS 
formation, it seems possible that cortical neurons were able to activate defense mechanisms against 
ROS levels. In fact, glutathione (Figure 6), SOD1 and GPX3 (Figure 7A,B) levels were significantly 
increased during the first 24 h of ODLG treatment. At 48 h of ODLG, glutathione reached values 
similar to controls. Reperfusion reversed the SOD1 and GPX3 upregulation although these values still 
remained higher than in controls (Figure 7A,B). Conversely, during reperfusion, when cells were 
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subjected to 1 to 5 h of hypoxia, glutathione levels were higher than in controls. However, these values 
were similar to controls at 24 and 48 h of ischemia (Figure 6). 
Figure 5. Effect of 1 to 48 h of ODLG on cytochrome oxidase activity. Results are  
means ± SEM in two experiments with cells from different cultures, each one performed  
in triplicate with different batches of cells (6 measurements/condition). ns = not significant 
(vs. control); NS = no significant (vs. ischemia with or without reperfusion); (*) = p < 0.05 
(vs. control); (**) = p <0.01 (vs. control); (•••) = p < 0.005 (vs. ischemia with or  
without reperfusion). 
 
Figure 6. Action of 1, 3, 5, 24 and 48 h of ODLG treatment on reduced glutathione levels, 
before and after 24 h of reperfusion. Results are means ± SEM of two experiments with 
cells from different cultures, each one performed in triplicate (6 measurements/condition). 
ns = no significant (vs. control); NS = no significant (vs. ischemia with or without 
reperfusion; (**) (vs.control) or (••) (vs. ischemia with or without reperfusion) = p < 0.01. 
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Figure 7. Effect of ODLG treatment on (A) SOD1 gene and (B) on GPX3 gene induction. 
ODLG = 24 h of ODLG exposure, ODLG + R = 24 h of ODLG exposure  
plus 24 h reperfusion. (***) (vs. control) or (•••) (ODLG vs. ODLG + R) = p < 0.005. 
 
2.8. Cellular and Mitochondrial Membrane Potential 
Twenty-four h of hypoxia plus hypoglycemia enhanced cellular membrane potential, suggesting 
that membrane depolarization was induced by ODLG (Figure 8A). However, low levels of ODLG did 
not alter the cellular membrane potential. A similar effect was observed in the mitochondrial 
membrane potential (PMM), which was increased at 12 h of ODLG (Figure 8B), again suggesting 
depolarization. These effects were not reversed during reperfusion. Shorter ODLG treatment times  
(1–3 h) did not affect the mitochondrial membrane potential. 
Figure 8. (A) Effect of 1, 2, 3 and 24 h of ODLG exposure on cell membrane potential; 
(B) Effect of ODLG on cell mitochondrial membrane potential at different ODLG 
exposure time. Results are means ± SEM of two experiments with cells from  
different cultures, each one performed in triplicate with different batches of cells  
(6 measurements/condition). ns = not significant (vs. control); NS = no significant  
(vs. I and IR); (•)= p < 0.05 (vs. I and IR) and (***)= p < 0.005 (vs. control).  
 
2.9. Cellular Functionality (Amino Acid Release) 
Finally, since neurotransmission regulates neuronal function, we used HPLC to measure amino acid 
neurotransmitter release mediated by high KCl in neurons subjected to ODLG for 24 h as well as in 
Int. J. Mol. Sci. 2014, 15 2482 
 
 
controls neurons (Figure 9). Our data indicate that Gly and GABA release were affected as compared 
to control release in controls. Gly release was higher in control than in ODLG-treated neurons; 
however the high KCl-induced GABA release was higher in treated neurons as compared to their 
controls. Nevertheless, ODLG treatment did not affect Asp and Glu release, suggesting that ischemia 
had only affected inhibitory synapses “in vitro”. 
Figure 9. Effect of ODLG on amino acid neurotransmitter release evoked by high 
potassium levels (60 mM). Results are means ± SEM of two experiments with cells from 
different cultures, each one performed in triplicate with different batches of cells  
(6 measurements/condition). The statistical significance was assessed by comparisons 
between controls and cells subjected to ODLG for 24 h. ns = not significant (vs. control); 
(*) = p < 0.05 (vs. control); (***) = p <0.005 (vs. control). 
 
3. Discussion 
3.1. HIF1α and HIF3α Are Upregulated during ODLG 
Our data clearly demonstrate that, under ODLG hypoxia factors HIF1α and HIF3α are upregulated 
in cortical neurons “in vitro”. This suggests that cortical neurons could develop adaptative responses to 
O2 deprivation “in vitro”. Although HIF1α levels were lower during reperfusion, they were still higher 
than in control conditions. In concordance with our findings, several authors have reported that HIF 1α 
and HIF 3α upregulation can prevent cell death from hypoxia [37,38]. Wu et al. [39] point out that 
HIF-1α contributes to early brain injury (EBI) after subarachnoid hemorrhage consisting of cell 
apoptosis, blood-brain-barrier (BBB) disruption, and brain edema through VEGF upregulation. These 
detrimental effects were prevented in the presence of the VEGF inhibitor, 2ME2. Our findings suggest 
that HIF-1α and HIF-3α upregulation may lead to adaptative responses against O2 deprivation in 
cortical neurons during hypoxia and even during reperfusion because although during this time the 
levels of HIF-1α and HIF-3α were decreased, the levels of these molecules were slightly higher than  
in controls. 
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3.2. ROS Generation and Antioxidant Mechanisms 
Unexpectedly, cortical neurons were able to survive in our experimental conditions of ODLG 
despite the very high ROS production. Thus, we are interested to understand the mechanisms involved 
in cell protection during this time. Our data indicate that increased glutathione together with SOD1  
and GPX3 overproduction under ODLG and even during reperfusion may prevent ROS-mediated 
damage in cortical neurons “in vitro”. In support of the antioxidant effects observed in our study,  
Chen et al. [40] showed that SOD1 was increased during the ischemia in astrocytes culture following 
oxygen glucose deprivation and reperfusion. 
Thus, SOD-1 overexpression may be an essential antioxidant mechanism that prevents neuronal 
death. Another study in rabbit spinal cords agreed with our findings and indicated that SOD1 protected 
neuron from spinal ischemic damage by both decreasing lipid peroxidation and maintaining catalase 
levels [41]. 
Collectively, these observations suggest that SOD-1 together with GPX3 overexpression is an 
adaptative response to oxygen deprivation that also occurred in our study. The reduced antioxidant 
SOD1 and GPX3 levels observed during reperfusion could decrease antioxidant responses during this 
time; this would coincide with strong caspase-3 activation during the reperfusion of cortical neurons 
subjected to ODLG during 24 h in the present study. 
Another point deserving mention is the formation of ROS during hypoxia/reperfusion. ROS 
formation requires O2 and, under O2 deprivation (hypoxia), cortical neurons are in an atmosphere of 
95% N2/5% CO2. ROS formation during hypoxia has been reported by several authors, who 
demonstrated ROS generation in complex III of the mitochondria respiratory chain during  
hypoxia [42]. In our opinion, the presence of ROS during hypoxia would be possible because during 
this process, NADH may accumulate. At the moment that cells are rescued from hypoxia, they have 
enough O2 to produce ROS despite the recent hypoxic conditions. Thus, ROS would not be formed 
during hypoxia although NADH might further accumulate. In fact, Livnat et al. [43] found increased 
NADH levels in the core and penumbra areas. 
3.3. Cytochrome Oxidase and ODLG 
During ODLG, cytochrome oxidase is lower during the first hour of hypoxia in cortical neurons but 
afterwards the enzyme shows a progressive recuperation in which it can even reach values similar to 
the control. This rise could reflect adaptative responses under vulnerability conditions. Cellular 
adaptation during ischemia has been previously reported by others who showed that preconditioning 
can protect against subsequent cellular insults [44–46]. 
3.4. ODLG and Cellular Death 
Although neuronal death by necrosis or apoptosis did not occur under ODLG conditions, there were 
deficits in physiological cellular respiration together with defective neurotransmission that could  
affect normal neuronal function. The decreases in metabolic ability generated during reperfusion  
could be due to ATP depletion. If ATP levels were depleted, caspase-3 might not be activated during 
reperfusion (as occurred in our experiments). As a consequence, neuronal survival could be preserved 
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during this period such as has been reported by Mattson and coworkers [47]. ATP depletion in cortical 
neurons during oxygen glucose deprivation (OGD) has been reported by others [48,49]. The lack of 
ATP does not necessarily induce cell death; thus, Yager et al. [50], studying hypoxic-ischemic damage 
in astrocytes, found that low ATP was not responsible for cell death. On the other hand, the lethargic 
state of cortical neurons during ODLG observed in our study by the XTT assay may protect them since 
such mechanisms can save energy, nutrients and O2 under vulnerable conditions. However, the lack of 
neuronal viability during reperfusion after 5 and 24 h of ODLG in our study suggests that: (1) there 
was cellular death or (2) there was an absence of recovery of the normal status during reperfusion. 
Through the crystal violet test or LDH and caspase-3 assays, our results indicated the absence of cell 
death by necrosis or apoptosis after 5 to 24 h of ODLG. Thus, we should not exclude the possibility 
that autophagy could have occurred during this time period. In fact, Arce et al. [50] showed that 
cortical neurons subjected to oxygen-glucose-deprivation (OGD) regulated BCL3, a protein involved 
in autophagy. Moreover, Zhang et al. [51] have reported that cerebral ischemia-reperfusion induces 
autophagy as a protective mechanism against neuronal injury. 
3.5. ODLG and Cellular Malfunction 
Additionally, cortical neurons may malfunction after a long period of ODLG since defective 
neurotransmission was detected together with dysfunctions in cellular and mitochondrial membrane 
potentials. Reperfusion after ischemia is a critical period that can lead to cell death as a consequence  
of mitochondrial membrane alterations during ODLG. In our study, the mitochondrial membrane 
potential increased at 12 h of ischemia, indicating membrane depolarization. However, this increase 
remained high after 24 h of reperfusion. These findings suggest that mitochondrial alterations cannot 
be reversed by reperfusion after a long ODLG treatment, so, the use of membrane protectors could 
preserve cellular integrity during this period. Our results suggest that mitochondrial alterations after 
ODLG may contribute to neuronal vulnerability even though apoptosis was not observed in our study. 
On the other hand, our results also show cellular membrane depolarization after 24 h of ODLG.  
This could affect neurotransmitter release (mainly glutamate) [47,48] under anoxia and hypoglycemia. 
Nevertheless, glutamate does not seem to be responsible for cellular death in our study, given the 
absence of cell death that was found in our experimental conditions. 
As a whole, our findings suggest that ODLG predisposes cortical neurons to cellular vulnerability 
and could resemble some neurotoxic mechanisms within the penumbra of ischemic rats and humans.  
In these conditions, cells are able to survive by inducing compensatory mechanisms that reduce 
neurodegeneration. The relevance of our findings is its potential to prevent cell death and repair 
damaged neurons in cerebral ischemia. The lack of O2 and low glucose could predispose neurons to 
vulnerable conditions as in the penumbral area, through ROS production. Nonetheless, cells are capable 
of surviving through compensatory defense/protective mechanisms under these vulnerable conditions 
(antioxidant defenses). However, part of these mechanisms could be lost at reperfusion, mainly as a 
consequence of mitochondrial membrane alteration under hypoxia. Cells under hypoxia could activate 
endogenous antioxidant mechanisms to ameliorate cell death and compensate for mitochondrial 
membrane imbalances [50]. Thus, the use of antioxidants does not seem to protect neurons during 
reperfusion because there was a reversion of ROS formation during this period. During induced ODLG, 
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neurons are able to activate endogenous antioxidant responses. Thus, the use of cellular and mitochondrial 
membrane protectors may be a good way to protect neurons during reperfusion after ischemia. 
4. Experimental Section 
4.1. Cell Isolation and Culture 
Brains from fetal (E19) rats of 19 days gestation were used. Brain neurons were obtained according 
to the procedure described by Segal [35] with minor modifications. Isolated neurons were suspended in 
EMEM medium with addition of 0.3 g/L glutamine, 3 g/L glucose, 10% FCS, 100 U/mL penicillin and 
100 µg/mL streptomycin. Cells, at a density of 106 cells/cm well, were placed on plastic Petri dishes 
treated with 10 µg/mL of poly-D-lysine, to attach them to the plates. Cells were then incubated in a 
humidified incubator with 5% CO2/95% air at 37 °C. After 72 h, the incubation medium was replaced 
with a fresh medium containing 10 µM of cytosine arabinoside to prevent glial overgrowth in the 
culture medium. Cells were studied after seven days “in vitro” (7 DIV). Cell purity was checked by 
staining cells both with cresyl violet to identify neurons and anti-GFAP antibody to identify atrocytes. 
Glial contamination was tested following the procedure from Figueroa et al. [36]. 
4.2. ODLG Treatment 
All experiments were performed at seven days of culture. The cultured medium was removed and 
replaced by an EMEM commercial medium containing 1 g/L glucose and 10% of fetal calf serum  
(low glucose). This treatment was performed on two sets of cells. Cells were placed for indicated time, 
in a chamber at 37 °C within an atmosphere of 95% N2/5% CO2 (O2 deprivation). After different times 
of ODLG, a set of cells was taken and several biochemical markers were assayed. 
Parallel control experiments were performed. In this case, the neurons were cultured with 
commercial EMEM medium plus 3 g/L of glucose under normal atmosphere (95% air/5% CO2). Thus, 
the controls were not under ODLG. 
4.3. Reperfusion 
After cells were subjected to ODLG for several periods of time (1, 3, 5, 12, 24 and 48 h), the 
medium was removed and replaced by normal medium (medium with serum plus antibiotics 
containing 3 g/L glucose plus 0.3 g/L glutamine). After this, cells were placed for 24 h, in a cell 
incubator containing 95% air/5% CO2 and 37 °C. At the end of this protocol, all parameters were 
evaluated for each experimental condition. 
4.4. Assessment of Cell Viability 
Cell viability was tested by crystal violet and the XTT assay. 
4.4.1. Crystal Violet Determination 
Cortical neurons were washed twice with PBS (8.1 mM Na2HPO4, 2.7 mM KH2PO4, 173 mM 
NaCl, pH 7.4) and then exposed to 0.2% crystal violet in 2% ethanol for 20 min. After this time, cells 
Int. J. Mol. Sci. 2014, 15 2486 
 
 
were washed with distilled water until the excess dye was removed and then were lysed by adding 1% 
sodium dodecyl sulfate (SDS). Finally, absorbance was measured at 560 nm. 
4.4.2. XTT Determination 
This assay is based on the ability of live metabolically active cells to reduce yellow tetrazolium salt 
(XTT) to form an orange formazan dye. Thus, this conversion can only occur in living cells. The 
newly-formed formazan dye is directly quantified using a scanning multi-well spectrophotometer at a 
wavelength of 492 nm (reference wavelength 690). The amount of orange formazan formed, as 
monitored by the absorbance, directly correlates to the number of living cells. Control and treated 
neurons were washed with PBS and incubated with the XTT solution (final concentration 0.3 mg/mL) 
according to Kit specifications. After this incubation period, orange dye solution was 
spectrophotometrically quantified at a wavelength of 492 nm (reference wavelength 690 nm). Results 
were expressed as percentages as compared to control cells, which were considered as 100%. 
4.5. Measurement of ROS Formation 
To assay ROS formation, 2,7-dichlorodihydrofluorescein diacetate (H2DCF-DA), a non-fluorescent 
lipophilic reagent, was used. H2DCF-DA enters the cells, where it is transformed into  
2,7-dichlorodihydrofluorescein (H2DCF) by the action of intracellular stearases. H2DCF is oxidized to 
fluorescent DCF by hydrogen peroxide. H2DCF-DA (5 µM) was added to the cells, before subjecting 
to different ODLG conditions. After each treatment, the incubation medium was removed and the  
cells were washed twice with PBS. Finally, fluorescence was measured in an FL600-BioTek 
spectrofluorometer (Winooski, VT, USA) with filters of 485/20 nm excitation and 530/25 nm 
emission. Results are expressed as arbitrary fluorescence units (AFU). 
4.6. Lactate Dehydrogenase (LDH) Release 
For LDH determination, the culture media from the control and experimental cultures treatments 
were collected and the neurons lysed by adding 0.1 M Tris-HCl (pH 7.4), containing 0.1% Triton  
X-100, and then centrifuged at 13,000 rpm using an Eppendorf centrifuge. LDH activity was measured 
in culture medium as well as in the cells according to López et al. [52]. Activity of LDH release is 
given as a percentage compared to the total LDH content (LDH in the supernatant + LDH inside  
the cells). 
4.7. Caspase-3 Activity Measurement 
Control and treated cortical neurons were washed with PBS and lysed with cell lysis buffer  
(10 mM Tris-HCl, 10 mM NaH2PO4/Na2HPO4, pH 7.5, 130 mM NaCl, 0.5% Triton X-100,  
10 mM Na4P2O7 and 2 mM dithiothreitol (DTT). Lysates were centrifuged at 13,000× g for 5 min. 
Caspase-3 activity was measured in the supernatants. Supernatants were incubated at 37 °C for 2–4 h 
in caspase-3 assay buffer (20 mM HEPES, pH 7.5, 10% glycerol, 2 mM DTT containing 20 µM Ac. 
N-acetyl-Asp-Glu-Val-Asp-(7-amino-4-methylcoumarin (AcDEVD-AMC). The fluorogenic  
7-amino-methylcoumarin (AMC) liberated from Ac-DEVD-AMC was monitored using a spectrofluorometer 
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Bio-Tek FL 600, at excitation wavelength of 360/20 nm and an emission wavelength range 460/20. 
Enzymatic activity is expressed as arbitrary fluorescence unit after 2 h per µg protein (AFU/2 h/µg 
protein). The amount of proteins in lysed cells was monitored by Bradford [53]. 
4.8. Cytochrome Oxidase Activity 
After each treatment, the incubation medium was removed and cells were washed with PBS and 
lysed with 200 µL of 0.1 M potassium phosphate buffer pH 7.5 which contained 0.5% Triton X-100. 
The lysed cells were centrifuged at 13,000 rpm for 5 min before collecting supernatants. Reduced 
cytochrome c (7 mg) was dissolved in 1 mL of 0.1 M of potassium phosphate buffer pH 7.5 and 
dithionite was added to ensure cytochrome reduction. Excess dithionite was removed by passing the 
cytochrome c solution through a Sephadex G-25 column equilibrated with the buffer (Amersham 
Bioscience, Arlington, MA, USA). The eluyent was taken and adjusted to an optic density of  
0.7 absorbance. The extract was added to 1 mL of this solution and absorbance measured at 550 nm. 
Activity was expressed as OD/10 min/mg protein. 
4.9. Measurement of Glutathione 
After treatments, the cultured medium was removed and cells washed with PBS. The cells were 
placed under ice and 300 µL of 0.1 M of sodium phosphate-EDTA pH = 8 and 100 µL of 25% 
phosphoric acid were added to each well. The cell suspension was centrifuged at 13,000× g for 5 min 
and the supernatant was taken. Glutathione concentration was expressed as AFU/µg protein. Reduced 
glutathione was evaluated following the protocol from Hissin and Hilf [54]. 
4.10. Measurement of Amino Acid Secretion 
HPLC analysis of amino acids was performed following a procedure from Márquez et al. [55].  
The cellular medium was removed and cells were washed twice with PBS. Cells were stimulated 
during 15 min at 37 °C with 0.5 mL of fresh Locke medium containing 60 mM KCl. After stimulation, 
the solution was taken and the amino acids in the solution were dansylated with dansyl chloride. 
Separation of dansyl-derivates was carried out in a 5 µM Spherisorb-ODS-2 column (15 × 0.46 cm; 
Sigma Aldrich, St. Louis, MO, USA) using a reversed-phase high-performance liquid chromatography 
with UV detection at 254 nm. Peaks were integrated using a Spectraphysic integrator (Sigma Aldrich) 
and quantified by comparison with simultaneously-prepared amino acid standards. Cells were lysed by 
adding 0.5 mL distilled water. The lysed cells were centrifuged at 13,000 rpm in an Eppendorf 
centrifuge (Hamburg, Germany) for 5 min and the supernatants were collected and proteins were 
measured. The amount of protein in the lysed cells was quantified using the Bradford assay [31]. 
Results were expressed as nmols of neurotransmitter/mg protein. 
4.11. Membrane Potential Measurement 
Changes in the membrane potential of neurons were monitored with the fluorescent dye bisoxonol 
(bis-[1,3-diethyl-thio-barbiturate]-trimethineoxonol), according to the Waggonet method [56].  
The control neurons, and neurons after treatment were washed and incubated with 0.2 µM bisoxonol 
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for 30 min. After this treatment, bisoxonol was removed and the cells were washed with PBS and 
suspended in PBS. Finally, fluorescence was measured at wavelengths of 540 nm excitation and  
565 nm emission, and monitored with a FL600-BioTek spectrofluorimeter Fluorescence (Winooski, 
VT, USA) intensity was reported as arbitrary fluorescence units. 
4.12. Mitochondrial Membrane Potential Assay 
Mitochondrial membrane potential was measured following the protocol by Tenneti et al., [57], 
with minor modifications. Control and treated cells were washed with PBS and incubated for 30 min 
with 500 nM of tetramethylrhodamine methyl ester (TMRM) and dissolved in Locke medium  
(140 mM NaCl, 4.4 mM KCl, 2.5 mM CaCl2, 1.2 mM MgSO4, 1.2 mM KH2PO4, 4 mM NaHCO3,  
5.5 mM glucose and 10 mM HEPES, adjusted to pH 7.5). Finally, cells were washed with PBS, and 
the fluorescence was measured using a FL600-BioTek spectrofluorimeter at 530/25 nm exc. and 
590/20 nm em. 
4.13. Analysis of Gene Expression 
Total RNA was isolated from 5 × 106 cells of primary neuron cultures, using a RNase mini kit from 
Qiagen, Hilden, Germany) following the manufacturer’s instructions with the optional RNase-free 
DNase step to avoid contamination with genomic DNA. RNA concentration was determined by 
spectrophotometer, reading absorbance at 260 nm and defining one optical density unit as equivalent  
to 40 µg/mL. The ratio between the absorbance values at 260 and 280 nm gave an estimation of  
RNA purity. 
4.13.1. RT-PCR Analysis 
RNasy Mini Kit (Qiagen, Valencia, CA, USA) was used for total RNA isolation. Reverse 
transcription (RT) was carried out for 1 h at 55 °C with oligodeoxythymidylate primer using 5 µg of 
total RNA from each sample for complementary DNA synthesis. 
Real time quantitative PCR to determine the levels of rat HIF1, HIF3, SOD1, GPX3 and 
housekeeping GAPDH mRNAs were performed using specific primers (See Table 1) synthesized at 
Sigma-Genosys (Oakville, ON, Canada). 
Table 1. mRNA primers. 
mRNA Primers 
HIF1α 5'-GAAACTCCAAAGCCACTTCG-3' (forward) 
5'-CTGGCTGATCTTGAATCTGG-3' (reverse) 
HIF3α 5'-GCTTATCTGTGAAGCCATCC-3' (forward) 
5'-CAACTTCTGCAATCCTCTCG-3' (reverse) 
SOD1 5'-GATGAAGAGAGGCATGTTGG-3' (forward) 
5'-CCAATGATGGAATGCTCTCC-3' (reverse) 
GPX3 5'-CATGAAGATCCATGACATCC-3' (forward) 
5'-GATGTCCATCTTGACGTTGC-3' (reverse) 
GAPDH 5'-AAGGGCTCATGACCACAGTC-3' (forward) 
5'-TTCAGCTCTGGGATGACCTT-3' (reverse) 
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4.13.2. Real-Time PCR 
The SYBR Green PCR Master Mix (Applied Biosystems, and the 7900 HT Fast Real-Time PCR 
System (Applied Biosystems, Foster City, CA, USA) were used to detect the real-time quantitative 
PCR products of reverse-transcribed cDNA samples, according to the manufacturer’s instructions.  
q-PCR conditions used are as follows: 95 °C (10 min), 40 cycles of 15 s at 95 °C and annealing for  
1 min at 60 °C. Two independent quantitative PCR assays were performed for each gene and measured 
in triplicate. Two non-template controls were run for each quantitative PCR assay, and genomic DNA 
contamination of total RNA minus controls (samples without the reverse transcriptase). 
4.14. Statistical Analysis 
Data are presented as means ± SEM of three/four independent experiments using different cell 
cultures, each one performed in triplicate with different batches of cells. Statistical comparisons 
between two or more populations were made using the ANOVA on rank test to evaluate the  
normality and variance of the data. If both parameters are confirmed then the Holme-Sidak test  
detects significant differences between groups. When one of these parameters is absent, we did a 
Kruskal-Wallis non-parametric analysis as well as Dunn’s pos Hoc test using the SigmaPlot  
11.0 software (Systat Software, Inc., San Jose, CA, USA).  
4.15. Ethics Statement 
Pregnant rats were obtained from the “Laboratory Animal form the Universidad Complutense of 
Madrid (U.C.M)”; License number #ES280790000086. The work was also approved by the University 
Animal Care Committee (C.E.A = Committee of Experimental Research and Ethics) from Universidad 
Complutense de Madrid (U.C.M); form number RD # 53/2013 for research and it was carried out in 
strict accordance with Guidelines for the Care and Use of Laboratory (European Council Directive 
86/609/EEC). All surgery was performed under sodium pentobarbital anesthesia, and all efforts were 
made to minimize suffering of animals. 
5. Conclusions 
The major points of the investigation presented here may be stated as follows: (1) Cortical neurons 
subjected to ODLG conditions (1–5 h) do not die but remain in lethargic stage. This condition protects 
neurons by saving energy and nutrients; (2) During this ODLG time cortical neurons showed 
protective mechanisms in their upregulation of HIF-1α and HIF-3α production as well as of 
antioxidant enzymes (reduced glutathione, SOD-1 and GPX3), which could help cells recover during 
reperfusion; and (3) After long ODLG times (12–24 h), cortical neurons are under the same conditions 
as those at shorter ODLG times, but during this longer period there is cell damage and mitochondrial 
membrane alterations which do not allow recovery during reperfusion. Taken together, these molecular 
events in our ODLG model are in accordance with some molecular aspects reported within the 
penumbra of ischemic rats [58]. Consequently, drugs that can induce HIF-1 and SOD-1 could helpful 
to recover after short periods of ischemia. 
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